Medpage Today on MSN16d
Leukemia Drug Shows Promise in Dementia With Lewy Bodies
The chronic myeloid leukemia drug nilotinib (Tasigna) improved biomarkers and cognitive outcomes in people with dementia with ...
McKnight's Long-Term Care News1d
Report: Dementia deaths fell in nursing homes, rose in private homes from 2018 to 2022
Deaths from dementia included deaths from conditions such as vascular dementia, unspecified dementia, Alzheimer’s disease and ...
Atlanta Journal-Constitution3d
CNN founder Ted Turner’s colorful life, legacy explored by Max in six parts
Ted Turner's colorful life is chronicled over six episodes on Max in a docuseries dubbed "Call Me Ted" out Nov. 13, 2024.
Annovis Invited to Present at National Institute on Aging Workshop on Dementia with Lewy Bodies (DLB)
MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...
McKnight's Long-Term Care News14d
Leukemia drug may help dementia with Lewy bodies
Nilotinib (Tasigna) — a drug for myeloid leukemia — improved biomarkers and cognitive outcomes in study participants with dementia with Lewy bodies, a new study finds.
Cognition Therapeutics Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update
CT1812 slowed cognitive decline by 95% in Alzheimer’s disease patients with lower levels of plasma p-tau217 in a pre-specified analysis from ...
Medscape10d
Leukemia Drug Shows Promise in Lewy Body Dementia
Nilotinib, a drug approved by the US Food and Drug Administration (FDA) to treat chronic myeloid leukemia, improved ...